nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00587	0.00587	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00585	0.00585	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00585	0.00585	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00579	0.00579	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00579	0.00579	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00567	0.00567	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00565	0.00565	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0056	0.0056	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00558	0.00558	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00556	0.00556	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HCRTR2—narcolepsy	0.00544	0.00544	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HCRTR1—narcolepsy	0.00544	0.00544	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—P2RY11—narcolepsy	0.00525	0.00525	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00523	0.00523	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00501	0.00501	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00501	0.00501	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00496	0.00496	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00496	0.00496	CbGpPWpGaD
Ipratropium bromide—CHRM5—G alpha (q) signalling events—NPS—narcolepsy	0.00488	0.00488	CbGpPWpGaD
Ipratropium bromide—CHRM5—G alpha (q) signalling events—TAC1—narcolepsy	0.00488	0.00488	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00486	0.00486	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00484	0.00484	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00479	0.00479	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00473	0.00473	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.00471	0.00471	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—PENK—narcolepsy	0.00457	0.00457	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00455	0.00455	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HCRT—narcolepsy	0.00447	0.00447	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00445	0.00445	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00423	0.00423	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00421	0.00421	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00413	0.00413	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00408	0.00408	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—PENK—narcolepsy	0.00398	0.00398	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00392	0.00392	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0039	0.0039	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00383	0.00383	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00383	0.00383	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00382	0.00382	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00378	0.00378	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.0037	0.0037	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00369	0.00369	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00367	0.00367	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00366	0.00366	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00365	0.00365	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00343	0.00343	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00341	0.00341	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00339	0.00339	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0032	0.0032	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00316	0.00316	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00309	0.00309	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00306	0.00306	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00306	0.00306	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Ipratropium bromide—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.0028	0.0028	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00235	0.00235	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00216	0.00216	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00207	0.00207	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00197	0.00197	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CHKB—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.00148	0.00148	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.00122	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PENK—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CPT1B—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TRH—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000979	0.000979	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000979	0.000979	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000976	0.000976	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000976	0.000976	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000966	0.000966	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000966	0.000966	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000953	0.000953	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00095	0.00095	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000941	0.000941	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CHKB—narcolepsy	0.00094	0.00094	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.0009	0.0009	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000889	0.000889	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000889	0.000889	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000886	0.000886	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000886	0.000886	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000877	0.000877	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000877	0.000877	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00085	0.00085	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000847	0.000847	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000839	0.000839	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000836	0.000836	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000759	0.000759	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000746	0.000746	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000746	0.000746	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000723	0.000723	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TRH—narcolepsy	0.00072	0.00072	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000713	0.000713	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000639	0.000639	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000634	0.000634	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000632	0.000632	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000625	0.000625	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CHKB—narcolepsy	0.000615	0.000615	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000589	0.000589	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000587	0.000587	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000581	0.000581	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000535	0.000535	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000533	0.000533	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000528	0.000528	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000525	0.000525	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000525	0.000525	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000523	0.000523	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000523	0.000523	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000518	0.000518	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000518	0.000518	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000449	0.000449	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000418	0.000418	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000316	0.000316	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000315	0.000315	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000312	0.000312	CbGpPWpGaD
